Pinnacle Bancorp Inc. Increases Stake in Zoetis Inc. (NYSE:ZTS)

Pinnacle Bancorp Inc. raised its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 8.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,595 shares of the company’s stock after purchasing an additional 285 shares during the quarter. Pinnacle Bancorp Inc.’s holdings in Zoetis were worth $702,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brevan Howard Capital Management LP lifted its position in shares of Zoetis by 7.9% during the fourth quarter. Brevan Howard Capital Management LP now owns 6,608 shares of the company’s stock worth $1,304,000 after acquiring an additional 482 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Zoetis by 31.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares in the last quarter. Peloton Wealth Strategists grew its holdings in Zoetis by 5.5% during the 4th quarter. Peloton Wealth Strategists now owns 9,839 shares of the company’s stock valued at $1,942,000 after buying an additional 509 shares in the last quarter. Able Wealth Management LLC purchased a new position in Zoetis during the 4th quarter valued at about $552,000. Finally, GLOBALT Investments LLC GA purchased a new stake in shares of Zoetis in the fourth quarter worth about $2,296,000. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on ZTS shares. Stifel Nicolaus raised their price objective on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler boosted their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Argus upgraded Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Finally, BTIG Research lifted their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, August 12th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Zoetis has a consensus rating of “Buy” and an average price target of $220.38.

Zoetis Trading Up 0.1 %

NYSE ZTS opened at $190.31 on Friday. The company has a quick ratio of 2.09, a current ratio of 3.45 and a debt-to-equity ratio of 1.32. The stock’s 50-day simple moving average is $187.72 and its two-hundred day simple moving average is $175.87. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The company has a market capitalization of $86.22 billion, a price-to-earnings ratio of 37.24, a PEG ratio of 2.95 and a beta of 0.89.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.07. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. Zoetis’s revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.41 earnings per share. Research analysts forecast that Zoetis Inc. will post 5.83 EPS for the current fiscal year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.